Verena Rubio‐Godoy

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909

Daniel E. Speiser, Danielle Líénard, Nathalie Rufer et al. · Journal of Clinical Investigation · 2005 · 621 citations · Full text

Effector Function of Human Tumor-Specific CD8 T Cells in Melanoma Lesions: A State of Local Functional Tolerance

Alfred Zippelius, Pascal Batard, Verena Rubio‐Godoy et al. · Cancer Research · 2004 · 363 citations

Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity.

Valérie Dutoit, Verena Rubio‐Godoy, Pierre‐Yves Dietrich et al. · PubMed · 2001 · 130 citations

Immunology, Pathology, Antigen Processing +17

Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity.

Danila Valmori, Carmen Scheibenbogen, Valérie Dutoit et al. · PubMed · 2002 · 106 citations

Tumor-reactive Cd8, Immunology, Immunoediting +21

Degeneracy of Antigen Recognition as the Molecular Basis for the High Frequency of Naive A2/Melan-A Peptide Multimer+ CD8+ T Cells in Humans

Valérie Dutoit, Verena Rubio‐Godoy, Mikäel J. Pittet et al. · The Journal of Experimental Medicine · 2002 · 101 citations · Full text